- Home
- NKTX vs STKS Comparison
NKTX vs STKS Comparison
Compare NKTX & STKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- STKS
- Stock Information
- Founded
- NKTX 2015
- STKS 2004
- Country
- NKTX United States
- STKS United States
- Employees
- NKTX N/A
- STKS N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- STKS Restaurants
- Sector
- NKTX Health Care
- STKS Consumer Discretionary
- Exchange
- NKTX Nasdaq
- STKS Nasdaq
- Market Cap
- NKTX 123.5M
- STKS 109.7M
- IPO Year
- NKTX 2020
- STKS N/A
- Fundamental
- Price
- NKTX $2.06
- STKS $2.57
- Analyst Decision
- NKTX Strong Buy
- STKS Hold
- Analyst Count
- NKTX 5
- STKS 3
- Target Price
- NKTX $13.50
- STKS $4.50
- AVG Volume (30 Days)
- NKTX 773.5K
- STKS 158.3K
- Earning Date
- NKTX 11-06-2025
- STKS 11-06-2025
- Dividend Yield
- NKTX N/A
- STKS N/A
- EPS Growth
- NKTX N/A
- STKS N/A
- EPS
- NKTX N/A
- STKS N/A
- Revenue
- NKTX N/A
- STKS $834,363,000.00
- Revenue This Year
- NKTX N/A
- STKS $26.58
- Revenue Next Year
- NKTX N/A
- STKS $5.37
- P/E Ratio
- NKTX N/A
- STKS N/A
- Revenue Growth
- NKTX N/A
- STKS 96.64
- 52 Week Low
- NKTX $1.31
- STKS $2.31
- 52 Week High
- NKTX $4.55
- STKS $5.26
- Technical
- Relative Strength Index (RSI)
- NKTX 46.37
- STKS 45.83
- Support Level
- NKTX $2.10
- STKS $2.34
- Resistance Level
- NKTX $2.24
- STKS $3.38
- Average True Range (ATR)
- NKTX 0.10
- STKS 0.26
- MACD
- NKTX 0.01
- STKS 0.01
- Stochastic Oscillator
- NKTX 39.39
- STKS 18.10
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
About STKS The ONE Group Hospitality Inc.
The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through four segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.